New Technology
Diasensor
|
Diasensor®, the world's first
noninvasive blood glucose monitor, painlessly and simply measures blood
glucose without the need to draw blood and without inconvenient,
expensive extra supplies.
Our model
demonstrates how the Diasensor operates by placing her forearm on the
arm tray and painlessly testing her blood sugar in less than two
minutes.
Visit the Diasensor site
The Diasensor 1000 -
A Breakthrough in Noninvasive Technology
The Diasensor 1000, the world’s
first commercially available noninvasive blood glucose monitor, is
approved for sale in the 15-nation European Union, where it is presently
being marketed. It is not yet approved by the FDA for sale in the United
States. Unlike currently marketed invasive home-use devices, the
Diasensor 1000 does not require that patients prick their fingers to
obtain a sample of blood to test their blood glucose. A patient only
needs to place his or her arm on the Diasensor 1000 and press a button
to perform a blood glucose test.
The Diasensor 2000 -
A Direct Link to the Clinician
The Diasensor 2000, identical in
appearance and operation to the Diasensor 1000, contains enhancements to
the operating software and a telemedicine feature to improve diabetes
management by clinicians.
|
Current Intended Use
of the Diasensor
Due to current limitations in this
brand new technology, the Diasensor is not for everyone. It is not
intended as a replacement for the current invasive home-use blood
glucose meter. It is intended to promote greater compliance for
self-monitoring for those patients concerned with the pain and
discomfort of frequent finger prick procedures by allowing patients to
perform the majority of their daily blood glucose monitoring with a
noninvasive device.
At this time, averages of blood
glucose test results obtained at clinically relevant times of the day
(e.g., fasting, pre-meal, post-meal and bedtime) over at least 15 to
30-day periods are intended to be used by physicians together with other
laboratory tests, such as glycosylated hemoglobin (HbA1c) and
fructosamine, patient-reported acute complications such as low blood
glucose (hypoglycemia), changes in weight and changes in lifestyle, to
adjust their patients’ diabetes therapy. Individual test results from
the Diasensor are not intended to be used by patients to make daily
adjustments to their insulin therapy, and the Diasensor should not be
used to detect or monitor for hypoglycemia.
|
